All the news

Conditional cash transfers – giving money to encourage use of services – may be needed to reach drug users for hepatitis C testing and treatment if they are either unaware of hepatitis ...

Despite access to hepatitis C treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the attitudes of healthcare workers, the difficulty of juggling treatment with competing demands, a ...

Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ...

Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ...

Lack of privacy, lack of peer support and lack of harm reduction are perceived as the biggest barriers to improving the uptake of direct-acting antiviral treatment for hepatitis C among prisoners, a qualitative ...

Direct-acting antiviral treatment is highly effective at curing hepatitis C in people who inject drugs and in people receiving opioid substitution therapy (OST), a systematic review and meta-analysis of 38 studies published ...